Hepatitis C virus epidemiology and prevention in Polish and Swiss population – similar and contrasting experiences

Benjamin Sakem 1, Kazimierz Madaliński 2, Urs Nydegger 1, Małgorzata Stępień 3, Paulina Godzik 3, Agnieszka Kołakowska 3, Lorenz Risch 1, Martin Risch 1, Karolina Zakrzewska 4, Magdalena Rosińska 5
1 - Labormedizinisches Zentrum Dr. Risch, Liebefeld, Switzerland
2 - National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
3 - National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
4 - 1. National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland; 2.Department of Epidemiology, Medical University of Warsaw, Poland
5 - National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
Ann Agric Environ Med
2016; 23 (3):
ICID: 1219181
Article type: Original article
 
 
Objective. The aim of the study was to review available data on HCV in Poland and Switzerland, in order to compare the two European countries with respect to epidemiological situation and efficiency of the response systems.
Materials and method. A search of registries, published and grey literature was performed to assemble data on prevalence, rate of detection of new cases, identified risk factors for transmission, mortality due to HCV, prevalence of HCC and the consequent liver transplantations, as well as data on treatment in Poland and Switzerland.
Results. Overall, the prevalence of anti-HCV antibodies was similar, not exceeding 1%. However, the major transmission routes of HCV infections were different: medical procedures in Poland and drug injections in Switzerland. By combining the available information it was also possible to demonstrate important differences in efficiency of the response systems. There was approximately 1 new diagnosis per 100 estimated undiagnosed cases in the population in Poland per year, compared to 6 in Switzerland, and the treatment rate per 100 estimated active infections was 2 and 4, respectively.
Conclusions. Scaling up of the diagnosis and treatment is necessary in both countries; however, the means to achieve this might differ, taking into account the higher concentration of the infections in risk groups in Switzerland than in Poland.
DOI: 10.5604/12321966.1219181
PMID 27660862 - click here to show this article in PubMed
  FULL TEXT STATS

Recommend this article to:

Name:
E-mail:
From:
Language:


Related articles in IndexCopernicus™
     access to treatment [1 related records]
     consequences of infection [0 related records]
     Poland and Switzerland [0 related records]
     epidemiological data [2 related records]
     acute and chronic HCV infection [0 related records]
     Hepatitis C [244 related records]



 

Related articles

T Aldámiz-Echevarría, J  González-García,
Association of baseline CD4+ cell count and HIV-RN...
Background and rationale for the study. We assessed the association of CD4+ T-cell counts and HIV-RNA on sustained viral response (SVR) after therapy with pegylated interferon and ribavirin (PR) in HIV/HCV coinfected patients. We examined two large c...
ABSTRACT
, ,
Epidemiological Survey of Hepatitis C in Yazd duri...
Background and Objective: The prevalence of hepatitis C infection is less than 1% in the general population, however the trend is increasing. Little is known about epidemiology of hepatitis C in Yazd according to population based data. This study was...
ABSTRACT
B PALAMAR,
HEPATITIS IN PATIENTS TREATED BY HEMODIALYSIS ...
During the last decades, according the international registers ( in 2011-2013) there is a steady increase of amount of patients with terminal kidney insufficiency. For the aim of continuation a life to such patients we apply the methods of renal rep...
ABSTRACT